232 related articles for article (PubMed ID: 16520463)
21. ATM polymorphism and hereditary nonpolyposis colorectal cancer (HNPCC) age of onset (United States).
Jones JS; Gu X; Lynch PM; Rodriguez-Bigas M; Amos CI; Frazier ML
Cancer Causes Control; 2005 Aug; 16(6):749-53. PubMed ID: 16049814
[TBL] [Abstract][Full Text] [Related]
22. Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer.
Dong X; Jiao L; Li Y; Evans DB; Wang H; Hess KR; Abbruzzese JL; Li D
J Clin Oncol; 2009 Apr; 27(10):1592-9. PubMed ID: 19237629
[TBL] [Abstract][Full Text] [Related]
23. Frameshift mutations at coding mononucleotide repeats of the hRAD50 gene in gastrointestinal carcinomas with microsatellite instability.
Kim NG; Choi YR; Baek MJ; Kim YH; Kang H; Kim NK; Min JS; Kim H
Cancer Res; 2001 Jan; 61(1):36-8. PubMed ID: 11196187
[TBL] [Abstract][Full Text] [Related]
24. A role for ATM in hereditary pancreatic cancer.
Bakker JL; de Winter JP
Cancer Discov; 2012 Jan; 2(1):14-5. PubMed ID: 22585162
[TBL] [Abstract][Full Text] [Related]
25. Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study.
Lozanski G; Ruppert AS; Heerema NA; Lozanski A; Lucas DM; Gordon A; Gribben JG; Morrison VA; Rai KM; Marcucci G; Larson RA; Byrd JC
Leuk Lymphoma; 2012 Sep; 53(9):1743-8. PubMed ID: 22369572
[TBL] [Abstract][Full Text] [Related]
26. Regarding: 'Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array'.
Pander J; Gelderblom H; van der Straaten T; Punt CJ; Guchelaar HJ
Br J Cancer; 2010 Jun; 102(12):1791-2. PubMed ID: 20531418
[No Abstract] [Full Text] [Related]
27. Lower ataxia telangiectasia mutated (ATM) mRNA expression is correlated with poor outcome of laryngeal and pharyngeal cancer patients.
Lee KW; Tsai YS; Chiang FY; Huang JL; Ho KY; Yang YH; Kuo WR; Chen MK; Lin CS
Ann Oncol; 2011 May; 22(5):1088-1093. PubMed ID: 21127011
[TBL] [Abstract][Full Text] [Related]
28. Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia.
Rudd MF; Sellick GS; Webb EL; Catovsky D; Houlston RS
Blood; 2006 Jul; 108(2):638-44. PubMed ID: 16574953
[TBL] [Abstract][Full Text] [Related]
29. A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.
Innocenti F; Owzar K; Cox NL; Evans P; Kubo M; Zembutsu H; Jiang C; Hollis D; Mushiroda T; Li L; Friedman P; Wang L; Glubb D; Hurwitz H; Giacomini KM; McLeod HL; Goldberg RM; Schilsky RL; Kindler HL; Nakamura Y; Ratain MJ
Clin Cancer Res; 2012 Jan; 18(2):577-84. PubMed ID: 22142827
[TBL] [Abstract][Full Text] [Related]
30. Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma.
Yin Z; Zhou B; He Q; Li M; Guan P; Li X; Cui Z; Xue X; Su M; Ma R; Bai W; Xia S; Jiang Y; Xu S; Lv Y; Li X
BMC Cancer; 2009 Dec; 9():439. PubMed ID: 20003463
[TBL] [Abstract][Full Text] [Related]
31. Association between DNA repair gene ATM polymorphisms and oral cancer susceptibility.
Bau DT; Chang CH; Tsai MH; Chiu CF; Tsou YA; Wang RF; Tsai CW; Tsai RY
Laryngoscope; 2010 Dec; 120(12):2417-22. PubMed ID: 21108427
[TBL] [Abstract][Full Text] [Related]
32. Functional variations in the ATM gene and susceptibility to differentiated thyroid carcinoma.
Xu L; Morari EC; Wei Q; Sturgis EM; Ward LS
J Clin Endocrinol Metab; 2012 Jun; 97(6):1913-21. PubMed ID: 22438227
[TBL] [Abstract][Full Text] [Related]
33. Genetic polymorphisms and treatment response in advanced non-small cell lung cancer.
Su D; Ma S; Liu P; Jiang Z; Lv W; Zhang Y; Deng Q; Smith S; Yu H
Lung Cancer; 2007 May; 56(2):281-8. PubMed ID: 17222938
[TBL] [Abstract][Full Text] [Related]
34. Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer.
Schrauder M; Frank S; Strissel PL; Lux MP; Bani MR; Rauh C; Sieber CC; Heusinger K; Hartmann A; Schulz-Wendtland R; Strick R; Beckmann MW; Fasching PA
J Cancer Res Clin Oncol; 2008 Aug; 134(8):873-82. PubMed ID: 18264724
[TBL] [Abstract][Full Text] [Related]
35. [Single nucleotide polymorphisms and point mutations of ataxia telangiectasia mutated gene in Chinese of Han ethnicity].
Tang HW; Bian JC; Jiang F; Shen Q; Zhu QX; Zhang HW; Wu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):579-82. PubMed ID: 15583986
[TBL] [Abstract][Full Text] [Related]
36. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
[TBL] [Abstract][Full Text] [Related]
37. Genetic variation in the DNA repair genes is predictive of outcome in lung cancer.
Matakidou A; el Galta R; Webb EL; Rudd MF; Bridle H; ; Eisen T; Houlston RS
Hum Mol Genet; 2007 Oct; 16(19):2333-40. PubMed ID: 17855454
[TBL] [Abstract][Full Text] [Related]
38. Impact of Polymorphic Variations of Gemcitabine Metabolism, DNA Damage Repair, and Drug-Resistance Genes on the Effect of High-Dose Chemotherapy for Relapsed or Refractory Lymphoid Malignancies.
Shinozuka K; Tang H; Jones RB; Li D; Nieto Y
Biol Blood Marrow Transplant; 2016 May; 22(5):843-9. PubMed ID: 26743341
[TBL] [Abstract][Full Text] [Related]
39. Predictive impact of genetic polymorphisms in DNA repair genes on susceptibility and therapeutic outcomes to colorectal cancer patients.
Sun K; Gong A; Liang P
Tumour Biol; 2015 Mar; 36(3):1549-59. PubMed ID: 25355595
[TBL] [Abstract][Full Text] [Related]
40. BLM is an early responder to DNA double-strand breaks.
Karmakar P; Seki M; Kanamori M; Hashiguchi K; Ohtsuki M; Murata E; Inoue E; Tada S; Lan L; Yasui A; Enomoto T
Biochem Biophys Res Commun; 2006 Sep; 348(1):62-9. PubMed ID: 16876111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
